Phathom Pharmaceuticals, Inc. (PHAT)
12.80
+0.13
(+1.03%)
USD |
NASDAQ |
Apr 15, 16:00
12.80
0.00 (0.00%)
After-Hours: 20:00
Phathom Pharmaceuticals Research and Development Expense (Annual) : 32.78M for Dec. 31, 2025
Research and Development Expense (Annual) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
R&D Expense Definition
R&D expense is a line item from many companies' income statements.
Research and Development Expense (Annual) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Research and Development Expense (Annual) Benchmarks
| Replimune Group, Inc. | 191.22M |
| ANI Pharmaceuticals, Inc. | 51.66M |
| MannKind Corp. | 66.35M |
| Ocugen, Inc. | 37.36M |
| Ligand Pharmaceuticals, Inc. | 81.18M |